- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 20FR12G Initial registration of securities (foreign private issuers)
- 1.1 Articles
- 1.2 Notice of Articles
- 4.1 Agreement Dated March 31, 2024 Between Bioharvest Israel and the Seller
- 4.2 Agreement Dated March 31, 2024 Among Bioharvest Israel, the Yavne No. 2 Landlord and the Seller
- 4.2 Agreement Dated March 31, 2024 Among Bioharvest Israel, the Yavne No. 2 Landlord and the Seller
- 4.3 Lease Agreement Dated March 31, 2024 Between Bioharvest Israel and the Yavne No. 2 Landlord
- 4.3 Lease Agreement Dated March 31, 2024 Between Bioharvest Israel and the Yavne No. 2 Landlord
- 4.4 Agreement Dated March 21, 2007 Between Bioharvest Israel and the Licensor
- 4.4 Agreement Dated March 21, 2007 Between Bioharvest Israel and the Licensor
- 4.5 Memorandum of Agreement Dated July 12, 2023 Between Bioharvest Israel and the TV Network
- 4.6 Development Agreement Dated January 1, 2024 Between the Company and the Biopharmaceutical Partner
- 4.7 Development Agreement Dated February 22, 2024 Between the Company and the Food Product Partner
- 4.8 Investor Relations Consulting Agreement Dated February 15, 2024 Between the Company and the MZ Group
- 4.9 Consulting Agreement Dated June 8, 2020 Between the Company and Ilan Sobel
- 4.10 Consulting Agreement Dated August 1, 2020 Among the Company, the M&S Group and Alan Rootenberg
- 4.11 Offer of Employment Dated February 10, 2010, As Last Amended on January 1, 2024, Between Bioharvest Israel and Yoheved Hagay
- 4.12 Employment Agreement Dated April 19, 2023 Between Bioharvest Israel and Ilana Belzer
- 4.13 Consulting Agreement Dated April 27, 2022, As Amended on January 1, 2024, Between the Company and Brian Cornblatt
- 4.14 Management Consulting Agreement Dated March 6, 2019 Among the Company, Ry-n Ginger and David Ryan
- 4.15 Stock Option Plan, As Amended and Restated on November 9, 2023
- 4.16 Equity Incentive Compensation Plan
- 8.1 Auditor Consent
- 15.1 List of Subsidiaries
- 29 Aug 24 6-K Current report (foreign)
- 29 Aug 24 6-K Current report (foreign)
- 22 Aug 24 20FR12G/A Initial registration of securities (foreign private issuers) (amended)
- 14 Aug 24 20FR12G/A Initial registration of securities (foreign private issuers) (amended)
- 24 Jul 24 20FR12G/A Initial registration of securities (foreign private issuers) (amended)
-
14 Jun 24 20FR12G Initial registration of securities (foreign private issuers)
- 22 Aug 24 Initial registration of securities (foreign private issuers) (amended)
- 14 Aug 24 Initial registration of securities (foreign private issuers) (amended)
- 24 Jul 24 Initial registration of securities (foreign private issuers) (amended)
- 14 Jun 24 Initial registration of securities (foreign private issuers)
|
|
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We hereby consent to the use in this Registration Statement on Form 20-F of BioHarvest Science Inc. and its subsidiaries (the “Company”) of our report dated May 26, 2024, except for the effects of the reverse stock split discussed in Note 26 (10) to the financial statements, as to which the date is June 14, 2024, related to the financial statements of the Company as of December 31, 2023 and December 31, 2022 and for the years then ended, which includes an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Registration Statement.
| /s/ Ziv Haft Certified Public Accountants (Isr.) BDO Member Firm |
Tel Aviv, Israel
June 14, 2024